|
US 12,391,726 B2 |
|
| Ursolic acid morpholine salt |
| John J. Talley, St. Louis, MO (US) |
| Assigned to EMMYON, INC., Rochester, MN (US) |
| Filed by EMMYON, INC., Rochester, MN (US) |
| Filed on Feb. 21, 2025, as Appl. No. 19/060,293. |
| Application 18/910,781 is a division of application No. 16/811,730, filed on Mar. 6, 2020. |
| Application 19/060,293 is a continuation of application No. 18/910,781, filed on Oct. 9, 2024, granted, now 12,264,178. |
| Application 16/811,730 is a continuation in part of application No. PCT/US2018/049742, filed on Sep. 6, 2018. |
| Claims priority of provisional application 62/649,938, filed on Mar. 29, 2018. |
| Claims priority of provisional application 62/558,004, filed on Sep. 13, 2017. |
| Prior Publication US 2025/0188114 A1, Jun. 12, 2025 |
| Int. Cl. A61K 45/06 (2006.01); A23L 29/00 (2016.01); C07J 63/00 (2006.01) |
